EC/ACP/WHO Partnership on Pharmaceutical Policies.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 1, p. 47
- Publication type:
- Article
Works matching IS 10109609 AND DT 2011 AND VI 25 AND IP 1
Results: 24
1
2
Good governance for medicines.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 1, p. 47
- Publication type:
- Article
3
Quality of antimalarials in sub-Saharan Africa.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 1, p. 46
- Publication type:
- Article
4
Assessment of 26 African regulatory authorities.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 1, p. 46
- Publication type:
- Article
5
ATC/DDD Classification (final).
- Published in:
- WHO Drug Information, 2011, v. 25, n. 1, p. 43
- Publication type:
- Article
6
ATC/DDD Classification (temporary).
- Published in:
- WHO Drug Information, 2011, v. 25, n. 1, p. 40
- Publication type:
- Article
7
Pandemic influenza vaccine (H5N1): withdrawal of marketing authorization application.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 1, p. 38
- Publication type:
- Article
8
Zoledronic acid: withdrawal of application for an extension of indication.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 1, p. 38
- Publication type:
- Article
9
Omacetaxine mepesuccinate: withdrawal of marketing authorization application.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 1, p. 38
- Publication type:
- Article
10
Briakinumab: withdrawal of marketing authorization application.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 1, p. 37
- Publication type:
- Article
11
Mometasone furoate/formoterol fumarate: withdrawal of marketing authorization application.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 1, p. 37
- Publication type:
- Article
12
Global operation against illegal and counterfeit medicines.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 1, p. 37
- Publication type:
- Article
13
Latest developments in pharmacovigilance.
- Published in:
- 2011
- Publication type:
- Proceeding
14
Bevacizumab use in breast cancer treatment.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 1, p. 33
- Publication type:
- Article
15
Sitaxentan: update following withdrawal.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 1, p. 32
- Publication type:
- Article
16
Dolasetron mesylate: abnormal heart rhythm.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 1, p. 32
- Publication type:
- Article
17
Dronedarone : severe liver injury.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 1, p. 31
- Publication type:
- Article
18
Tamoxifen and antidepressants: drug interaction.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 1, p. 30
- Publication type:
- Article
19
Clozapine and life-threatening gastrointestinal hypomotility.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 1, p. 29
- Publication type:
- Article
20
Methysergide and retroperitoneal fibrosis.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 1, p. 28
- Publication type:
- Article
21
ENCePP launch electronic register of studies.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 1, p. 28
- Publication type:
- Article
22
WHO Prequalification of Medicines Programme.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 1, p. 24
- Publication type:
- Article
23
14th International Conference of Drug Regulatory Authorities.
- Published in:
- 2011
- Publication type:
- Proceeding
24
International Conference of Drug Regulatory Authorities: personal reminiscences.
- Published in:
- WHO Drug Information, 2011, v. 25, n. 1, p. 18
- By:
- Publication type:
- Article